
Deep learning approach for lung cavity estimation manuscript published
Now published in the Journal of Magnetic Resonance Imaging: A dual-channel deep learning approach for lung cavity estimation from hyperpolarized gas and proton MRI.
Read MoreThe NOVEL observational longiTudinal studY (NOVELTY) is a global, prospective, 3-year observational study of patients with a diagnosis or suspected diagnosis of asthma and/or COPD, with an additional 2-year extension study at participating sites. NOVELTY aims to describe patient characteristics, treatment patterns and disease burden over time across the spectrum of obstructive lung disease, providing real-world evidence to advance the development of precision medicine to deliver the right treatment to the right patient at the right time. The NOVELTY study is sponsored by AstraZeneca.
Now published in the Journal of Magnetic Resonance Imaging: A dual-channel deep learning approach for lung cavity estimation from hyperpolarized gas and proton MRI.
Read MoreThe newly published GOLD 2023 report cites the ‘Treatable traits in the NOVELTY study’ article.
Read MoreNow published in Respiratory Medicine: Frequent productive cough: Symptom burden and future exacerbation risk among patients with asthma and/or COPD in the NOVELTY study.
Read MoreRead summaries of publications and presentations relating to the NOVELTY study and access useful NOVELTY resources.
Read MoreYou are now leaving: http://aznoveltyproject.com/
By following this link you will be leaving the NOVELTY study website.
Please note that AstraZeneca does not take responsibility for the content displayed on other websites.